Serious Side Effects (Both Drugs Carry These) Both medications carry an identical FDA boxed warning for thyroid C-cell tumours and share these serious risks: Thyroid C-cell tumours contraindicated with personal/family history of medullary thyroid carcinoma or MEN 2 Pancreatitis discontinue and seek care for severe, persistent abdominal pain Gallbladder disease gallstones, partly from rapid weight loss Hypoglycaemia especially if combined with insulin or sulfonylureas Acute kidney injury from dehydration during vomiting/diarrhoea Aspiration risk during surgery inform your anaesthesiologist, as both delay gastric emptying Cost Comparison: Zepbound vs Wegovy in 2026 Cost and insurance coverage frequently decide the final prescription
Not directly
Dim your lightsyou can set smart bulbs to turn on to dim settings at sunsetand take a warm shower
Body Protection Compound-157 (BPC-157) earned the "healing peptide" label through its broad, multi-system reparative activity observed across preclinical models, covering muscle, tendon, ligament, bone, and gastrointestinal tissue repair
Therefore, a protein-based formulation with no/low toxicity risks should be implemented in the transporters
If you notice any of the following, seek emergency medical attention immediately: Swelling of the face, lips, tongue, or throat Trouble swallowing or breathing Severe rash or itching Fainting Very rapid heartbeat Nausea and vomiting The same study found that females were about 4.5 times more likely to experience vomiting when taking GLP-1 drugs
